BRENTUXIMAB for Chemotherapy: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 10 adverse event reports in the FDA FAERS database where BRENTUXIMAB was used for Chemotherapy.
Most Reported Side Effects for BRENTUXIMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 40 | 22.2% | 13 | 21 |
| Drug ineffective | 30 | 16.7% | 7 | 9 |
| Disease progression | 23 | 12.8% | 6 | 2 |
| Febrile neutropenia | 14 | 7.8% | 0 | 9 |
| Malignant neoplasm progression | 13 | 7.2% | 7 | 7 |
| Neuropathy peripheral | 10 | 5.6% | 0 | 5 |
| Product use in unapproved indication | 9 | 5.0% | 2 | 5 |
| Tubulointerstitial nephritis | 9 | 5.0% | 0 | 8 |
| Acute kidney injury | 8 | 4.4% | 1 | 8 |
| Pancytopenia | 8 | 4.4% | 1 | 6 |
| Sepsis | 8 | 4.4% | 4 | 3 |
| Vomiting | 8 | 4.4% | 1 | 5 |
| C-reactive protein increased | 7 | 3.9% | 0 | 6 |
| Covid-19 | 7 | 3.9% | 4 | 6 |
| Disease recurrence | 7 | 3.9% | 0 | 0 |
Other Indications for BRENTUXIMAB
Hodgkin's disease (61)
Diffuse large b-cell lymphoma (18)
Cutaneous t-cell lymphoma (15)
Product used for unknown indication (13)
Anaplastic large cell lymphoma t- and null-cell types (9)
Hodgkin's disease recurrent (8)
Adult t-cell lymphoma/leukaemia (6)
Non-hodgkin's lymphoma (5)
Primary mediastinal large b-cell lymphoma recurrent (5)
Other Drugs Used for Chemotherapy
CYCLOPHOSPHAMIDE (3,372)
DOCETAXEL (2,134)
CARBOPLATIN (1,902)
DOXORUBICIN (1,756)
VINCRISTINE (1,743)
PACLITAXEL (1,425)
OXALIPLATIN (1,423)
METHOTREXATE (1,380)
CYTARABINE (1,355)
ETOPOSIDE (1,246)